Articles by Sanjay Garg, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Sanjay Garg, PhD

Biopharmaceutical Form and Function

A timely new book explains techniques for conformational analysis.
Jun 2, 2010

A timely new book explains techniques for conformational analysis.

Quality in, Quality Out

A book guides readers through the regulatory requirements for computerized quality systems.
Jun 2, 2009

A book guides readers through the regulatory requirements for computerized quality systems.

A Peak in Mass-Spectrometry Literature

A book about pharmaceutical analysis engages the reader with history and unexpected asides.
Dec 2, 2008

A book about pharmaceutical analysis engages the reader with history and unexpected asides.

Charting a Path to Purity

Regulators and industry professionals provide a guide for identifying and measuring impurities.
Oct 2, 2007

Regulators and industry professionals provide a guide for identifying and measuring impurities.

An Update on Osmotic Drug Delivery

Aug 2, 2003

The authors review patent literature that describes new developments in osmotic drug delivery such as pulsatile, delayed, and volume amplifier delivery devices.

Current Status of Drug Delivery Technologies and Future Directions

Feb 2, 2001

Evolution of an existing drug molecule from a conventional form to a novel delivery system can significantly improve its performance in terms of patient compliance, safety, and efficacy. These days,drug delivery companies are engaged in the development of multiple platform technologies to get competitive advantage, extend patent life, and increase market share of their products.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here